Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06635993 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion

Study acronym: ABOARD
StatusRecruiting
PhaseNot specified
SponsorQifu Li
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 10, 2024 (before its estimated August 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Qifu Li
6 trials monitored
See all monitored trials
To evaluate the accuracy of 68Ga-Pentixafor PET-CT in the classification diagnosis of primary aldosteronism concurrent with autonomous cortisol secretion patient, using AVS and/or postoperative remission as the reference standard for classification diagnosis.
Trial Details
NCT Number NCT06635993
Lead Sponsor Qifu Li
Collaborators: The First Affiliated Hospital of Zhengzhou University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Third Xiangya Hospital of Central South University, The Affiliated Hospital Of Southwest Medical University
Conditions
(from sponsor)		 Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Related terms Hyperaldosteronism
Enrollment 97 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov